Whalesbook
Fortis Hospitals Limited, a wholly-owned subsidiary of Fortis Healthcare, has received an Income Tax order for ₹149.12 crore for Assessment Year 2021-22.
Fortis Healthcare Limited announced on April 1, 2026, that its subsidiary, Fortis Hospitals Limited, received the Income Tax order dated March 31, 2026. The order concerns Assessment Year (AY) 2021-22 and involves a demand of ₹149.12 crore. Fortis Hospitals is evaluating how to respond, considering options like filing an appeal or a rectification application.
A tax demand of this size can significantly affect a company's financial performance and cash reserves if not settled favorably. Management will need to focus on legal and administrative steps to manage potential outflows. The subsidiary's success in contesting or resolving the demand efficiently will be important for its financial health. This situation also highlights the need for strong tax compliance and dispute resolution strategies, and may lead to increased costs for legal and administrative processes.
Fortis Healthcare has a history of tax-related issues. In May 2025, a ₹89.53 crore tax demand against a subsidiary for AY 2022-23 was overturned by a rectification order. More recently, in March 2026, Fortis Hospitals Ltd. received another tax demand of ₹117.04 crore for AY 2024-25. In December 2025, the company also reported GST orders confirming demands totaling ₹2139.61 lakhs for FY 2020-21 through 2022-23. Looking further back, the company's founders resigned in February 2018 amidst allegations of fund siphoning.
If the Income Tax department upholds the demand, it could result in significant financial outflows that affect profitability and cash reserves. The outcome and timing of any appeal or rectification process remain uncertain. Frequent tax demands might also suggest persistent issues with tax compliance or regulatory interpretation.
Fortis Healthcare operates in a competitive landscape with major hospital chains such as Apollo Hospitals and Max Healthcare. For FY25, Apollo Hospitals reported revenue of ₹21,794 crore, Max Healthcare recorded ₹7,028 crore, and Fortis Healthcare posted ₹7,783 crore. Max Healthcare leads in revenue per bed among these peers. However, direct comparisons regarding tax liabilities are not publicly disclosed.
Investors will be monitoring Fortis Healthcare's decision on whether to file an appeal or rectification application. Updates on the progress and outcome of the company's evaluation of the tax demand will be key. Further communication or rulings from the Income Tax Authority, as well as any developments on other ongoing tax and legal matters concerning the company and its subsidiaries, will also be important.